Skip to content

The impact of transcutaneous acupoint electrical stimulation on core body temperature during anesthesia in patients undergoing intracavitary urological surgery

The impact of transcutaneous acupoint electrical stimulation on core body temperature during anesthesia in patients undergoing intracavitary urological surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080925
Enrollment
Unknown
Registered
2024-02-18
Start date
2024-06-23
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative hypothermia

Interventions

Transcutaneous acupoint electrical stimulation(TEAS) group:In the intervention group (TEAS group), the skin of the patients was disinfected at Dazhui (GV 14), Mingmen (GV 14) and bilateral Neiguan (PC
Sham stimulation group:In the sham stimulation group (CON group), the skin of Dazhui (GV 14), Mingmen (GV 4) and Neiguan (PC 6) was disinfected, the electrodes were attached, and the acupoint stimulat

Sponsors

Department of Anesthesia and Perioperative Medicine, the First Affiliated Hospital of Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Age 18-65; 2)ASA I-II level; 3) Performing elective intracavitary urological surgery; 4) Expected anesthesia time =60min; 5) Intravenous anesthesia was performed; 6) Voluntary signing of anesthesia consent and experimental informed consent;

Exclusion criteria

Exclusion criteria: 1) Patients with abnormal tympanic membrane temperature during anesthesia preparation, such as 35kg/m2; 3) Carbon dioxide was injected into the abdomen; 4) It is not suitable for patients with percutaneous acupoint electrical stimulation, such as skin infection, nerve damage in the lower back, spinal deformity, and electronic implants in the body after the instrument leads through the surgical site or acupoints; 5) Patients with diseases that affect body temperature, such as thyroid dysfunction, pituitary tumor, and history of infectious fever within 2 weeks; 6) Patients with preoperative hemodynamic instability, such as bradycardia (HR 120 times /min), uncontrolled hypertension (SBP> 180 mmHg), hypotension (SBP < 90 mmHg); 7) Patients who have participated in other clinical trials in the last 4 weeks; 8) Patients who are unable to cooperate with the completion of the research plan, such as mental illness, language difficulties, consciousness disorders or infectious diseases; 9) Patients who are not considered suitable for participation in this study by other investigators;

Design outcomes

Primary

MeasureTime frame
Incidence of hypothermia during anesthesia;

Secondary

MeasureTime frame
Core temperatures during anesthesia were recorded at Tb(during anesthesia preparation), T0 (at the end of anesthesia induction) and every 20min thereafter;Area under the time/temperature curve of T0, T1, T2, and T3;The proportion of normal body temperature during anesthesia at the end of induction and at intervals of 20 minutes thereafter;Incidence of postoperative chills;Recovery time (the ability to stop the drug to call);Intraoperative drug dosage;QoR-15 scale score 24 hours after surgery;Forced air heating device;

Countries

China

Contacts

Public ContactHaixing Zhong

Department of Anesthesia and Perioperative Medicine, the First Affiliated Hospital of Air Force Medical University

Haixing.zhong@139.com+86 139 9194 6615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026